This announcement is a separate document:
迈普医学：广州迈普再生医学科技股份有限公司2024年限制性股票激励计划
Medprin Regenerative Medical Technologies: Guangzhou Maitai Regenerative Medical Technology Co., Ltd.'s restricted stock incentive plan for 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.